Kairos Pharma, Ltd.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Antibodies
- Pharmaceuticals
See more in Biomedtracker
Latest on Kairos Pharma, Ltd.
Scrip
• By Mandy Jackson
BioAge Labs, Inc. switched the development focus for its lead drug candidate, the small molecule apelin receptor (APJ) agonist azelaprag, from age-related muscle loss to prevention of muscle loss in
Scrip
• By Elizabeth Cairns
Stock market listings were back on the upswing last quarter, with the eight biotechs floating on Western exchanges raising a total of $1.1bn. In fact, there seems to have been a bit of a rush: three c
Scrip
• By Mandy Jackson
Biopharmaceutical companies celebrated recent positive data readouts with a slew of significant follow-on public offerings (FOPOs), including Nuvalent, Inc. , which grossed $500m on 16 September from